Cargando…
Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer
To evaluate the role of ubiquitin-conjugating enzyme E2C (UBE2C) in prostate cancer (PCa) progression and prognosis, the TCGA and our PCa tissue microarray cohort were included in the study. Weighted gene co-expression network analysis (WGCNA) and non-negative matrix factorization were used to clust...
Autores principales: | Wu, Xiaobo, Long, Xingbo, Ma, Chenkai, Cheuk, Yin Celeste, Hu, Mengbo, Hu, Jimeng, Jiang, Haowen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695011/ https://www.ncbi.nlm.nih.gov/pubmed/36430352 http://dx.doi.org/10.3390/ijms232213873 |
Ejemplares similares
-
Anticancer effect of icaritin on prostate cancer via regulating miR‐381‐3p and its target gene UBE2C
por: Hu, Jimeng, et al.
Publicado: (2019) -
Icaritin reduces prostate cancer progression via inhibiting high-fat diet-induced serum adipokine in TRAMP mice model
por: Wu, Xiaobo, et al.
Publicado: (2020) -
Ubiquitin-Conjugating Enzymes in Cancer
por: Bui, Quyen Thu, et al.
Publicado: (2021) -
m(6)A Methylation Regulators Are Predictive Biomarkers for Tumour Metastasis in Prostate Cancer
por: Liang, Yingchun, et al.
Publicado: (2022) -
The Ubiquitin Conjugating Enzyme: An Important Ubiquitin Transfer Platform in Ubiquitin-Proteasome System
por: Liu, Weigang, et al.
Publicado: (2020)